HealWELL AI Inc. Stock Price, News & Analysis

HEALWELL AI (OTCQX: HWAIF) appointed Ian Kidson to its Board of Directors, effective December 10, 2025.

Kidson brings decades of financial, governance, and healthcare-related corporate leadership across public and private companies in Canada and the U.S., including roles as CFO at Docebo (2019–2021), CFO and CEO at Apollo Health Corp., EVP & CFO at Progressive Waste Solutions (before its 2016 merger with Waste Connections), and senior capital markets positions at CIBC Wood Gundy and TD Capital Mezzanine Partners. HEALWELL said his financial expertise and experience guiding organizations through growth will support its focus on early identification and detection of disease.

HEALWELL (OTCQX: HWAIF) reported Q3-2025 revenue of $30.4M, a 354% increase year‑over‑year driven largely by the Orion Health acquisition. Subscription, support and maintenance revenue rose to $21.0M (+535%). The company posted positive Adjusted EBITDA of $0.7M versus a loss of $2.8M in Q3‑2024, its second consecutive quarter of positive adjusted EBITDA. IFRS net loss from continuing operations was $16.0M (up 83% YoY). HEALWELL exercised its call option to acquire the remaining 49% of Pentavere and launched AmadeusAI integrating DARWEN™. Subsequent divestments and transactions strengthened the balance sheet with approximately $9.7M in cash proceeds, positioning the company as a pure‑play AI, SaaS and services healthcare provider.

HEALWELL AI (OTCQX: HWAIF) completed related‑party transactions with WELL affiliates to become a pure‑play SaaS, services and AI company focused on enterprise healthcare. The Transactions closed Nov 1, 2025, and include: sale of Polyclinic clinics for $1.2M cash plus up to $1.2M earn‑out; sale of HEALWELL's 58.66% Mutuo interest for $8,212,400 (with $615,930 four‑month holdback); and a 50/50 clinical research JV funded with $3.0M contributed by each party and an initial $500k capital call. HEALWELL reports a ~$120M revenue run rate and Adjusted EBITDA profitability, and received approximately $9.4M cash on closing.

HEALWELL AI (OTCQX: HWAIF) and subsidiary Orion Health signed a Memorandum of Understanding with Lean Business Services to explore development and commercialization of AI-driven digital health across the Middle East and Orion's global markets.

The MoU, signed on October 28, 2025 at the Global Health Exhibition in Riyadh, targets AI population health, clinical AI, and data interoperability, including integration with Saudi Arabia's NPHIES platform. Orion Health's regional footprint includes Malaffi (connecting 3,000 facilities, 13 million patients) and a Saudi HIE linking over 5,000 providers and serving > 30 million people.

HEALWELL AI (OTCQX: HWAIF, TSX: AIDX) will release Fiscal Third Quarter 2025 results for the period ended September 30, 2025 on Thursday, November 6, 2025. The company will host a conference call and simultaneous webcast to discuss results on Friday, November 7, 2025 at 8:30 AM ET / 5:30 AM PT.

The call will be hosted by James Lee (CEO), Dr. Alexander Dobranowski (President) and Anthony Lam (CFO). Webcast access and dial-in details are provided for North American and international participants.

HEALWELL AI (OTCQX: HWAIF) filed an amended and restated business acquisition report dated October 24, 2025, relating to its acquisition of Orion Health Holdings Limited, which closed on April 1, 2025. The Amended BAR replaces the prior BAR filed June 30, 2025.

The amendment updates the audit report to confirm compliance with the International Standards on Auditing (ISA) rather than ISA (New Zealand) and adds disclosure about the auditor’s responsibilities as required by ISA. The filing was made at the request of staff of the Ontario Securities Commission. The Amended BAR is available on SEDAR+.

HEALWELL AI (OTCQX: HWAIF) completed a week-long UK business development roadshow, including an invitation-only London event on October 14, 2025. Management — including CEO James Lee and President Dr. Alexander Dobranowski — met prospective investors, partners, and M&A targets and emphasized AI-driven preventative healthcare, clinician decision support, and HEALWELL's role supporting the UK National Health Service. The company highlighted plans to leverage its recently acquired Orion Health business to accelerate growth across UK markets and internationally, and reported strong engagement from UK banks, healthcare providers, and institutional investors.

HEALWELL (OTCQX: HWAIF) reported that its DARWEN™ AI platform generated regulatory-grade real-world data (RWD) supporting vedolizumab dose escalation from every 8 weeks to every 4 weeks, with improved remission outcomes for ulcerative colitis and Crohn's disease.

HEALWELL presented these AI-generated RWD findings with Takeda on October 6, 2025 at UEG Week in Berlin. The company says DARWEN has 40+ peer-reviewed publications and was named a finalist in Newsweek's AI Impact Awards 2025.

HEALWELL AI (OTCQX: HWAIF) has announced the global launch of AmadeusAI, a significant milestone in integrating DARWEN™ AI technology with Orion Health's Amadeus platform. The enhanced platform introduces the SMARTSuite of AI tools, including SMARTSearch, SMARTSummary, and SMARTIdentify.

AmadeusAI builds upon Orion Health's established Amadeus Digital Care Record, which has served over 150 million patients across 15 countries. The platform consolidates health and social care data into a comprehensive patient view, enabling healthcare providers to analyze clinical data, identify at-risk patients, and make informed decisions at the point of care.

The upgrade is now available to existing Amadeus customers, representing a key proof point of the Orion Health acquisition's success. The platform has been previously deployed across major healthcare systems including NHS Integrated Care Systems, U.S. Health Information Exchanges, and various national health networks.